Could a diabetes drug help leg artery disease? new study investigates
NCT ID NCT07340112
First seen Jan 14, 2026 · Last updated Apr 25, 2026 · Updated 12 times
Summary
This observational study will measure the level of a protein called GLP1 receptor on blood cells from 50 adults with peripheral artery disease (PAD). The goal is to see if this receptor is linked to disease severity and inflammation, which could mean that existing GLP1 agonist drugs (used for diabetes) might one day help treat PAD. Participants give one extra blood sample during a routine visit; no new treatments are tested.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE (PAD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.